See the DrugPatentWatch profile for insulin
Sopn insulin refers to a brand name for a type of insulin used to manage diabetes. Specifically, it is a rapid-acting insulin analog.
When does Sopn insulin's patent expire?
Information on the specific patent expiry for Sopn insulin is not readily available in the provided context. Patent data for insulin products can be complex, often involving multiple patents for different aspects of the drug, including its formulation, method of use, and manufacturing. For detailed patent information, resources like DrugPatentWatch.com can provide comprehensive listings of patent statuses and expiry dates [1].
What is Sopn insulin used for?
Sopn insulin is used to control high blood sugar in adults and children with diabetes. It is typically administered before meals to help manage post-meal blood glucose levels. It works by helping the body use glucose from food for energy or store it for later use.
How does Sopn insulin work?
As a rapid-acting insulin analog, Sopn insulin begins to work quickly after injection, usually within 15 minutes. It binds to insulin receptors on cells, enabling glucose to enter the cells from the bloodstream. This process lowers blood glucose levels. Its rapid onset and short duration of action make it suitable for mealtime insulin therapy.
What are the different types of insulin?
Insulin products are generally categorized by their onset of action, peak time, and duration. These categories include:
* Rapid-acting insulins: Like Sopn, these start working within 15 minutes and last for 2-4 hours.
* Short-acting insulins: These begin working in about 30 minutes and last for 6-8 hours.
* Intermediate-acting insulins: These take effect in 1-2 hours and last for 10-18 hours.
* Long-acting insulins: These start working in 1-2 hours and can last for 24 hours or longer.
* Ultra long-acting insulins: These provide very long-lasting coverage.
* Pre-mixed insulins: Combinations of rapid-acting and intermediate-acting or short-acting and intermediate-acting insulins.
Who makes Sopn insulin?
The manufacturer of Sopn insulin is not specified in the provided information. Typically, insulin products are developed and marketed by major pharmaceutical companies specializing in diabetes care.
What are the risks or side effects of Sopn insulin?
The most common side effect of Sopn insulin, and all insulins, is hypoglycemia, or low blood sugar. Symptoms can include shakiness, sweating, confusion, dizziness, and rapid heartbeat. Other potential side effects may include injection site reactions like redness, swelling, or itching, and weight gain.
How is Sopn insulin administered?
Sopn insulin is administered via subcutaneous injection, usually into the abdomen, thigh, or upper arm. It is not typically administered intravenously unless under specific medical supervision.
Sources:
[1] https://drugpatentwatch.com